Skip to main content

Table 1 Correlations between ANLN expression and clinicopathological characteristics of patients with pancreatic cancer

From: ANLN-induced EZH2 upregulation promotes pancreatic cancer progression by mediating miR-218-5p/LASP1 signaling axis

Variable

All cases

ANLN

P value

Low expression

High expression

Age

0.429

  ≤ 60

37

20

17

  > 60

43

27

16

Gender

 Male

46

26

20

0.638

 Female

34

21

13

Tumor size (cm)

  < 2

41

31

10

0.002**

  ≥ 2

39

16

23

Tumor differentiation

 Well

36

26

10

0.027*

 Poor

44

21

23

TNM stage

 I + II

25

22

3

0.000**

 III + IV

55

25

30

Lymph node metastasis

 Negative

49

35

14

0.004**

 Positive

31

12

19

Distant metastasis

 M0

53

37

16

0.005**

 M1

27

10

17

  1. *Statistically significant (P < 0.05), **Statistically significant (P < 0.01)